ArticleMolecular therapy. Nucleic acids2026

sncRNA levels predict SNORD105B is a novel biomarker of chronic kidney disease risk and SGLT2 inhibitor response in type 2 diabetes.

Juliette A de Klerk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.